Value of serum and bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants

European Cytokine Network

Volumn 23, Issue 2, 2012, Pages 29-35

  Köksal, Nilgün ^a   Kayik, Bülent ^a   Çetinkaya, Merih ^a   Özkan, Hilal ^a   Budak, Ferah ^a   Kiliç, Şebnem ^a   Canitez, Yakup ^a   Oral, Barbaros ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Anti inflammatory cytokine; Bronchopulmonary dysplasia; Prematurity; Pro inflammatory cytokine

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; LUNG DYSPLASIA; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PREDICTIVE VALUE; PREMATURITY; PROTEIN BLOOD LEVEL; TRACHEAL ASPIRATION PROCEDURE;

BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOPULMONARY DYSPLASIA; CYTOKINES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863879483     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2012.0304     Document Type: Article

References (43)

1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Resp Crit Care Med 2001; 163: 1723.
2. Gien J, Kinsella JP. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr 2011; 23: 305.
3. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birth weight of infants. Am J Obstet Gynecol 2007; 196: e1.
4. Van Marter LJ. Epidemiology of bronchopulmonary dysplasia. Sem Fetal Neonatal Med 2009; 14: 358.
5. Speer CP. Inflammation and bronchopulmonary dysplasia. Sem Neonatol 2003; 8: 29.
6. SpeerCP. Pulmonary inflammation and bronchopulmonary dysplasia J Perinat 2006; 26: S57.
7. Jaarsma A, BraaksmaMA, GevenWB, et al. Activation of the inflammatory reaction within minutes after birth in ventilated preterm lambs with neonatal respiratory distress syndrome. Biol Neonate 2004; 86: 1.
8. Kotecha S. Pathophysiology of chronic lung disease or prematurity. Biol Neonate 2000; 78: 233.
9. Jonsson B, Li YH, Noack G, et al. Down regulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity. Acta Paediatr 2000; 89: 1375.
10. Keane MP, Strieter RM. The importance of balanced proinflammatory and anti-inflammatory mechanisms in diffuse lung disease. Respir Res 2002; 3: 5.
11. Goodman RB, Pugin J, Lee JS, et al. Cytokine mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003; 14: 523.
12. Belperio JA, Keane MP, Lynch JP, et al. The role of cytokines during the pathogenesis of ventilator-associated and ventilator-induced lung injury. Semin Respir Crit Care Med 2006; 27: 350.
13. Strieter RM, Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Invest 2002; 109: 699.
14. Kotecha S, Wilson L, Wangoo A, et al. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 1996; 40: 250.
15. Baier RJ, Majid A, Parupia H, et al. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr Pulmonol 2004; 37: 137.
16. Vento G, Capoluongo E, Matassa PG, et al. Serum levels of seven cytokines inpremature ventilated newborns: correlations with old and new forms of bronchopulmonary dysplasia. Intensive Care Med 2006; 32: 723.
17. Viscardi RM, Muhumuza CK, Rodriguez A, et al. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 2004; 55: 1009.
18. Paananen R, Husa AK, Vuolteennaho R, et al. Blood cytokines during the perinatal period in very premature infants: relationship of inflammatory response and bronchopulmonary dysplasia. J Pediatr 2009; 154: 39.
19. Walti H, Couchard M, Relier JP. Neonatal diagnosis of respiratory distress syndrome. Eur Respir J 1989; 2: 22.
20. Papile LA, Burstein J, Burstein R. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J Pediatr 1978; 92: 529.
21. WalshMC, KliegmanRM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986; 33: 179.
22. International Committee for the Classification of Retinopathy of Prematurity, The International Classification of Retinopathy of Prematurity revisited. Arch Ophtalmol 2005; 123: 991.
23. Ballard JL, Khoury JC, Wedig L, et al. New Ballard Score expanded to include extremely premature infants. JPediatr 1991; 119: 417-423.
24. Baraldi E, Carraro S, Filippone M. Bronchopulmonary dysplasia: definitions and long term respiratory outcome. Early Hum Dev 2009; 85: S1.
25. Schulzke SV, Pillow JJ. The management of evolving bronchopulmonary dysplasia. Paediatr Resp Rev 2010; 11: 143.
26. Jankov RP, KeithTanswell A. Growth factors, postnatal growth factor and bronchopulmonary dysplasia. Paediatr Resp Rev 2004; 5: S265.
27. Bose CL, Dammann CEL, Laughon MM. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 2008; 93: F455.
28. Bry K, Whitsett AJ, Lappalainen U. IL-1_ disrupts postnatal lung morphogenesis in the mouse. Am J Resp Cell Mol Biol 2007; 36: 32.
29. Rindfleisch MS, Hasday JD, Taciak V, et al. Potential role of interleukin-1 in the development of bronchopulmonary dysplasia. J Interferon Cytokine Res 1996; 16: 365.
30. Jonsson B, Tullus K, Brauner A, et al. Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 1997; 77: F198.
31. Ambalavanan N, CarloWA, D'Angio CT, et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009; 123: 1132.
32. Johnson BH, Yi M, Masood A, et al. A critical role for the IL-1 receptor in lung injury induced in neonatal rats by 60% O2. Pediatr Res 2009; 66: 260.
33. Munshi UK, Niu JO, Siddiq MM, et al. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol 1997: 24: 331.
34. Bagchi A, Viscardi RM, Taciak V, et al. Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res 1994; 36: 244.
35. van der Meer P, Blackwell TS, Lawrence S, et al. Fibroblast growth factor-10 expression through inhibition of Sp1-mediated NF-kB activation limits airway branching, J Immunol 2010; 185: 4896.
36. Mahieu LM, De Dooy JJ, Ieven MM, et al. Increased levels of tumor necrosis factor-alpha and decreased levels of interleukin-12 p 70 in tracheal aspirates, within 2 hrs after birth, are associated with mortality among ventilated preterm infants. Pediatr Crit Care Med 2005; 6: 682.
37. Tullus K, Noack GW, Burman LG, et al. Elevated cytokine levels in trachebronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr 1996; 155: 112.
38. Bourbia A, Cruz MA, Rozycki HJ. NF-kappa B in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen and outcome. Arch Dis Child Fetal Neonatal Ed 2006; 91: F36.
39. Spits H, de Waal Malefyt R. Functional characterization of human IL-10. Int Arch Allergy Immunol 1992; 99: 8.
40. Blahnik MJ, Ramanathan R, Riley CR, et al. Lipopolysaccharideinduced tumor necrosis factor-alpha and IL-10 production by lung macrophages from preterm and term neonates. Pediatr Res 2001; 50: 726.
41. Jones CA, Cayabyab RG, Kwong KY, et al. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996; 39: 966.
42. Beresford MW, Shaw NJ. Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome. Pediatr Res 202; 52: 973.
43. Choi CW, Kim BL, Kim HS, et al. Increase of interleukin-6 in tracheal aspirate at birth: A predictor of subsequent bronchopulmonary dysplasia in preterm infants. Acta Paediatr 2006; 95: 38.